Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

Dec 2020| TBR1231A| TBRC (Publisher)

Report Highlights

Including: By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases
By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types

Covering: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the human microbiome therapeutics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global human microbiome therapeutics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography and segmentation by disease, and by sequencing technology type.
  • Market Characteristics – The market characteristics section of the report defines and explains the human microbiome therapeutics market. This chapter also defines and describes products covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global human microbiome therapeutics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the human microbiome therapeutics market.
  • Global Market Size And Growth – This section contains the global forecast (2023-2025), (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the forecast periods.
  • Regional Analysis – This section contains the forecast (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2023-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size forecast (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global human microbiome therapeutics market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for human microbiome therapeutics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global human microbiome therapeutics market is segmented into -

By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases
By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types

Companies Mentioned: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 

  • Table 1 : Global Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 2 : Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, %
  • Table 3 : Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, $ Million
  • Table 4 : Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, %
  • Table 5 : Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, $ Million
  • Table 6 : Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 7 : Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 8 : Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, %
  • Table 9 : Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, $ Million
  • Table 12 : Asia Pacific Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 13 : Asia Pacific Oncology Drugs Market, 2015-2019, $ Billion
  • Table 14 : Asia Pacific Gastrointestinal Market, 2015-2019, $ Billion
  • Table 15 : Asia Pacific Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 16 : Asia-Pacific Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 17 : Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 18 : Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 19 : China Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 20 : China Oncology Drugs Market, 2015-2019, $ Billion
  • Table 21 : China Gastrointestinal Market, 2015-2019, $ Billion
  • Table 22 : China Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 23 : China Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 24 : China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 25 : China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 26 : India Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 27 : India Oncology Drugs Market, 2015-2019, $ Billion
  • Table 28 : India Gastrointestinal Market, 2015-2019, $ Billion
  • Table 29 : India Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 30 : India Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 31 : India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 32 : India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 33 : Japan Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 34 : Japan Oncology Drugs Market, 2015-2019, $ Billion
  • Table 35 : Japan Pacific Gastrointestinal Market, 2015-2019, $ Billion
  • Table 36 : Japan Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 37 : Japan Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 38 : Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 39 : Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 40 : Australia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 41 : Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 42 : Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 43 : Indonesia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 44 : Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 45 : Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 46 : South Korea Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 47 : South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 48 : South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 49 : Western Europe Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 50 : Western Europe Oncology Drugs Market, 2015-2019, $ Billion
  • Table 51 : Western Europe Gastrointestinal Market, 2015-2019, $ Billion
  • Table 52 : Western Europe Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 53 : Western Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 54 : Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 55 : Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 56 : UK Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 57 : UK Oncology Drugs Market, 2015-2019, $ Billion
  • Table 58 : UK Gastrointestinal Market, 2015-2019, $ Billion
  • Table 59 : UK Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 60 : UK Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 61 : UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 62 : UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 63 : Germany Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 64 : Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 65 : Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 66 : France Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 67 : France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 68 : France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 69 : Eastern Europe Metabolic Drugs Market, 2015-2019, $ Billion
  • Table 70 : Eastern Europe Oncology Drugs Market, 2015-2019, $ Billion
  • Table 71 : Eastern Europe Gastrointestinal Market, 2015-2019, $ Billion
  • Table 72 : Eastern Europe Anti-infective Drugs Market, 2015-2019, $ Bllion
  • Table 73 : Eastern Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 74 : Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 75 : Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 76 : Russia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 77 : Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 78 : Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 79 : North America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 80 : North America Oncology Drugs Market, 2015-2019, $ Billion
  • Table 81 : North America Gastrointestinal Market, 2015-2019, $ Billion
  • Table 82 : North America Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 83 : North America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 84 : North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 85 : North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 86 : USA Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 87 : USA Oncology Drugs Market, 2015-2019, $ Billion
  • Table 88 : USA Gastrointestinal Market, 2015-2019, $ Billion
  • Table 89 : USA Anti-infective Drugs Market, 2015-2019, $ Bullion
  • Table 90 : USA Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 91 : USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 92 : USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 93 : South America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 94 : South America Oncology Drugs Market, 2015-2019, $ Billion
  • Table 95 : South America Gastrointestinal Market, 2015-2019, $ Billion
  • Table 96 : South America Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 97 : South America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 98 : South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 99 : South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 100 : Brazil Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 101 : Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 102 : Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 103 : Middle East Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 104 : Middle East Oncology Drugs Market, 2015-2019, $ Billion
  • Table 105 : Middle East Gastrointestinal Market, 2015-2019, $ Billion
  • Table 106 : Middle East Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 107 : Middle East Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 108 : Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 109 : Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 110 : Africa Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 111 : Africa Oncology Drugs Market, 2015-2019, $ Billion
  • Table 112 : Africa Gastrointestinal Market, 2015-2019, $ Billion
  • Table 113 : Africa Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 114 : Africa Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Table 115 : Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Table 116 : Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
  • Table 117 : Global Human Microbiome Therapeutics Market, Key Competitor Estimated Ranks, 2019
  • Table 118 : Seres Therapeutics - Financial Performance, 2016 - 2019, $ Billion
  • Table 119 : Global Human Microbiome Therapeutics Market Size Gain ($ Million), 2023 - 2030, By Country
  • Table 120 : Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Disease, 2023 - 2030
  • Table 121 : Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Sequencing Technology Type, 2023 - 2030
  • Table 122 : Human Microbiome Therapeutics Market Data Sources
  • Figure 1 : Global Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 2 : Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, %
  • Figure 3 : Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, %
  • Figure 4 : Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 5 : Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, %
  • Figure 7 : Asia-Pacific Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 8 : Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 9 : China Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 10 : China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 11 : India Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 12 : India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 13 : Japan Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 14 : Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 15 : Australia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 16 : Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 17 : Indonesia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 18 : Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 19 : South Korea Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 20 : South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 21 : Western Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 22 : Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 23 : UK Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 24 : UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 25 : Germany Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 26 : Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 27 : France Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 28 : France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 29 : Eastern Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 30 : Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 31 : Russia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 32 : Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 33 : North America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 34 : North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 35 : USA Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 36 : USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 37 : South America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 38 : South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 39 : Brazil Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 40 : Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 41 : Middle East Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 42 : Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 43 : Africa Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
  • Figure 44 : Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
  • Figure 45 : Seres Therapeutics - Financial Performance, 2016 - 2019, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report